Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A First in Human, Randomized, Double-Blind Study to Assess Safety and Tolerability, Pharmacokinetic and Pharmacodynamic Effects of HTD4010 in Healthy Participants

NCT02538848 is registered in ClinicalTrials.gov with HighTide Therapeutics (Hong Kong) Limited as lead sponsor.

NCT NCT02538848
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02538848 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A First in Human, Randomized, Double-Blind Study to Assess Safety and Tolerability, Pharmacokinetic and Pharmacodynamic Effects of HTD4010 in Healthy Participants
Lead sponsor
HighTide Therapeutics (Hong Kong) Limited
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2015
Completion date
March 31, 2016
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus